Merck Sharp & Dohme MK-8931-019-017
Back to Drug Development Trials
![]()
Drug Development Trials
About the trial
A Parallel-Group, Double-Blind, Long Term Safety and Efficacy Trial of MK-8931 (SCH 900931) in Subjects with Amnestic Mild Cognitive Impairment Due to Alzheimer’s Disease (Prodromal AD).
